MCP 5 Flashcards
1. discuss and apply the principles of imprinting, imprinting failure, disomy, isodisomy and heterodisomy in clinical practice 2. compare and contrast prader-willi and angelman syndromes, including the biological causes and the relationship to chromosomal abnormalities imprinting and UPD 3. discuss epigenetics and explain how epigenetic modifications are related to disease
Traits of Prader willi
small, hypotonic at birth, begin to gain weight because they overeat. small hands, small feet, hypogonadisum and bad temper, developmentally delayed and most to well in special education or group homes
Traits of Angelman
severely MR, cannot carry on usually conversations but friendly, bursts of inappropriate laughter, hyperacitivty, short stature, microcephaly, seizures, ataxia (happy puppet symdrome)
Causes of Prader willi
- paternal deletion
- maternal disomy (uniparental disomy)
- maternal imprinting pattern (inherited from father) -> functionally maternal chromosomes although one from mom one from dad
Causes of Angelman
- maternal deletion
- paternal disomy
- paternal imprinting pattern (one from mom one from dad but maternal chromosome has paternal imprinting pattern–> functionally paternal chromosomes)
Uniparental disomy
inheritance of a chromosome or chromosomes from 1 parent to the exclusion of the other
-cannot be detected by karyotype analysis must use molecular probe and even then we cannot tell if they are the same copy isodisomy or heterodisomic
Uniparental isodisomy
- usually a result of meiotic nondisjunction –> monosomy
- zygote rescue duplicated the lone chromosme leading to the 2 copies of one
- mechanism has been identified in some CF patients
Uniparental heterodisomy
- usually a result of meiotic nondisjunction–> trisomy
- zygote rescue randomly inactivates one chromosome (or deletes one) –> 2/3 of the time the desirable biparental heterodisomy is achieved but 1/3 of the time it leads to two different copies from one parent
Imprinting
the differential modification of the maternal and paternal genetic contributions to the zygote resulting in the differential expression of parental alleles during development and in the adult
there are male and female differences
-lasts one generation
-change usually occurs at meiosis
Methylation
- addition of methyl groups to cytosine residues in the DNA–> essentially turns genes off because there is no transcription (blocks binding of other cofactors and activators)
- can occur within a single gene or a group of adjacent genes
- can occur over a portion of a single chromosome
- can occur over the full length of one or more chromosomes
- the pattern of methylation can be different between males and females
PWS and AS genes pattern of disfunction
- three genes SNRPN, necdin and UBE3A
- maternal pattern turns off SNRPN and necidin
- paternal pattern turns off UBE3A
- so patient needs copies of 2 chromosomes with appropriate imprinting pattern to have all genes expressed
Are all chromosomes imprinted?
no
- 14 and 15 are
- large number of developmental genes are imprinted important for development of early zygote -> type of mutation is not usually associated with a change in DNA sequence but rather expression
Epigentics
- the study of heritable changes in gene function that are NOT caused by a change in the DNA sequence
- modification of transcription that alters gene expression and thus phenotype
- this is a normal process required for “normal” cell function
- change in epigenetic effects can result in up or down regulation of genes and this can result in disease
What are the primary categories of epigenetic modifications?
- histone modification
- chromatin remodeling
- DNA methylation
Transcription factors
- bind to DNA and alter gene transcription
- act as an activator or repressor
- bind specifically to enhancer or promoter regions of the DNA adjacent to a specific gene
MicroRNA (miRNA)
- small non coding RNAs
- miRNA bind to mRNA to regulate gene expression-> this can prevent translation or interfere with the translation process
- down regulation of miRNA caused by hypermethylation at miRNA promoters is reported in a number of tumors
- provide therapy targets and drug development